期刊文献+

成分输血在异位妊娠出血并弥漫性血管内凝血时的作用 被引量:12

Blood Component Therapy in Emergency Treatment of Ectopic Pregnancy Complicated with Disseminated Intravascular Coagulation
下载PDF
导出
摘要 目的观察并探讨成分输血在抢救异位妊娠出血弥漫性血管内凝血(DIC)时的作用。方法选取我院妇产科异位妊娠合并DIC产妇62例,随机分成对照组和治疗组各31例;对照组病人依需求输注红细胞悬液和血浆,治疗组病人采用成分输血,在输注红细胞悬液和血浆的基础上加用冷沉淀以及冷冻血小板。比较两组产妇输血后血色素(HGB)、红细胞比容(HCT)、血小板数(PLT)、凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)以及纤维蛋白原(FGB)有无差别。结果抢救成功后,治疗组产妇HGB、HCT和TT检验指标与对照组差异无统计学意义(P>0.05)。而治疗组在PLT、PT、APTT和FGB等方面的改善优于对照组(P<0.05)。结论成分输血适用于异位妊娠大出血,尤其对改善大出血引起的DIC及相应并发症有重要作用。 OBJECTIVE To observe the use of blood component therapy in gynecologic ectopic pregnancy complicated by disseminated intravascular coagulation(DIC)in the emergency. METHODS 62 patients with ectopic pregnancy complicated by DIC were randomly divided into two groups. Control group(31 cases) only used the red suspension and plasma, treatment group(31 cases) added with fresh frozen plasma, frozen platelets, cryoprecipitate. The hemoglobin(HGB), hematocrit(HCT), platelet count(PLT), prothrombin time(PT), thrombin time(TT), activated partial clotting enzyme live time(APTT) and fibrinogen(FGB) of two groups were tested and compared after blood transfusion. RESULTS Treatment group and control group in the HGB, HCT, PT and TT testing had no significant difference(P〉0.05), but the PLT, PT, APTT, and FGB of treatment group were better than control group(P〈0.05).CONCLUSIONS Component transfusion is suitable for gynecologic ectopic pregnancy hemorrhage, especially plays an important role for improving of DIC caused by massive hemorrhage.
作者 谢辉霞
出处 《中国初级卫生保健》 2014年第5期48-49,共2页 Chinese Primary Health Care
关键词 成分输血 异位妊娠 弥漫性血管内凝血 blood component transfusion ectopic pregnancy DIC
  • 相关文献

参考文献5

二级参考文献48

  • 1张振钧.凝血功能障碍致产后出血的防治[J].中国实用妇科与产科杂志,1993,9(4):204-206. 被引量:26
  • 2刘棣临.妊娠期凝血不合理应用[J].实用妇产科杂志,1992,8(1):8-8.
  • 3张钦辉.临床输血学[M].上海:上海科学技术出版社,2006:265.
  • 4Raife TJ,Rosenfeld SB,Lentz SR,et al.Bleeding from acquired coagulation defects and antithrombotic therapy.In:Simon TL,Dzik WH,Snyder EL,et al.Rossi′s principles of transfusion medicine[M].3rd ed.Philadelphia:Lipplncott Williams& Wilkins,2004:399.
  • 5Watanabe R,Wada H,Miura Y,et al.Plasma levels of total plasminogen activator inhibitor-1(PAI-1)and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura[J].Clin Apll Thromb Hemost,2001,7(3):229-233.
  • 6Levi M,ten Cate H.Disseminated intravascular coagulation[J].N Engl J Med,1999,341(8):586-592.
  • 7Bick RL.Disseminated intravascular coagulation.Current concepts of etiology,pathophysiology,diagnosis,and treatment[J].Hematol Oncol Clin N Am,2003 17(1):149-176.
  • 8Levi M,de Jonge E,Meijers J.The diagnosis of disseminated intravascular coagulation[J].Blood Rev,2002,16(4):217-223.
  • 9Mammen EF.Disseminated intravascular coagulation(DIC)[J].Clin Lab Sci,2000,13(4):239-245.
  • 10Levi M.Disseminated intravascular coagulation[J].Crit Care Med,2007,35(9):2191-2195.

共引文献46

同被引文献99

引证文献12

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部